Search
for
Sort by
Research 451–480 of 1000+
- Dermatolojik Problemler ve COVID-19
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- Contaminants of emerging concern in the fetal environment
- The Impact of Covid-19 Pandemic on the Clinical Course of Pediatric Skin Disorders: A Cross-Sectional Study
- Manifestaciones dermatológicas por Covid-19 y su aporte en la comprensión de la enfermedad
- Swastyayanam of Bhela indriya Sthana - an explorative study
- Eficacia y seguridad del plasma rico en plaquetas intralesional comparado con minoxidil al 5% tópico en el tratamiento de la alopecia androgenética masculina con afectación en vértex
- Penopubic Junction Reconstruction Using a Pedicled Superficial Circumflex Iliac Artery Perforator Flap
- Dermatomyositis Disease in Dogs
- Effect of Exercise Interventions on Metabolic, Reproductive and Mental Health in Overweight Women with Polycystic Ovary Syndrome
- Dermatological Manifestations of COVID-19: A Brief Review
- Nitroglycerin in Dermatology
- PATTERN OF CUTANEOUS MANIFESTATIONS OF DIABETES MELLITUS
- Live Imaging of the Skin Immune Responses
- A Review on change in chemical, morphological and therapeutic activity of honey
- British Hair and Nail Society
- Détection précoce de la cardiotoxicité due à la doxorubicine chez le miniporc par imagerie par résonance magnétique
- Issue Information - TOC
- Evaluation of the role of soluble receptors for advanced glycosylated end-products in polycystic ovarian syndrome
- V Congress of the Portuguese Society of Cosmetological Sciences - Proceedings
- Capillaroscopic patterns in patients with systemic sclerosis, psoriasis and alopecia and their correlations with serum concentrations of several angiogenic markers
- Megassessões de unidades foliculares e fatores de crescimento plaquetário
- Polycystic Ovary Syndrome and Cardiovascular Disease
- Wound healing
- SUMMARIES OF PAPERS
- Registrars’ Symposium: Summaries of Papers
- Syndromes of Severe Insulin Resistance (SSIRs)
- NEW PROPRIETARY BRANDS: Gabapentin
- NEW PROPRIETARY BRANDS: Cephalexin
- New drugs: Agalsidase beta